Three institutions in Camden are teaming up for a unique approach to fighting opioid addiction.
The Coriell Institute for Medical Research, Cooper University Health Care, and Cooper Medical School of Rowan University are launching the Camden Opioid Research Initiative (CORI), to investigate the genetic and biological factors that contribute to the development of opioid use disorder.
CORI will capitalize on Coriell’s expertise in genomics, biobanking and personalized medicine; Cooper University Health Care’s clinical infrastructure and expertise in treating opioid use disorder patients; and Cooper Medical School of Rowan University’s reputation for scientific excellence in genetics, the neurosciences and addiction research.
The CORI team has established a pair of studies. The first will focus on chronic pain patients, while the second will enroll patients currently participating in Cooper's addiction medicine program.